| Product NDC: | 60505-0750 |
| Proprietary Name: | Ceftriaxone Sodium |
| Non Proprietary Name: | Ceftriaxone Sodium |
| Active Ingredient(s): | 250 mg/1 & nbsp; Ceftriaxone Sodium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-0750 |
| Labeler Name: | Apotex Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065230 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050802 |
| Package NDC: | 60505-0750-0 |
| Package Description: | 1 VIAL in 1 BOX (60505-0750-0) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| NDC Code | 60505-0750-0 |
| Proprietary Name | Ceftriaxone Sodium |
| Package Description | 1 VIAL in 1 BOX (60505-0750-0) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 60505-0750 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ceftriaxone Sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20050802 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corporation |
| Substance Name | CEFTRIAXONE SODIUM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |